Imunon
IMNN
20 hedge funds and large institutions have $1.82M invested in Imunon in 2017 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 4 closing their positions.
886% more call options, than puts
Call options by funds: $69K | Put options by funds: $7K
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
225% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 4
91% more capital invested
Capital invested by funds: $956K → $1.82M (+$866K)
82% more funds holding
Funds holding: 11 → 20 (+9)
0.02% less ownership
Funds ownership: 0.04% → 0.02% (-0.02%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$753K |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$175K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$123K |
| 4 |
VF
Virtu Financial
New York
|
+$122K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$62.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$473K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$101K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$59K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$17K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$1.14K |
IMNN Hedge Fund Activity: Q4 2017 in Review
20 of the 4,419 institutional investors tracked by Wall St. Rank reported a position in Imunon (IMNN) for Q4 2017, worth a combined $1.82M — up 91% from $956K a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new IMNN positions and 4 closed out — a net gain of 9 holders — while 4 added to existing stakes and 1 trimmed.
The largest buyer was Vanguard Group, adding an estimated $753K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $473K sold.
- 20 institutional investors held Imunon (IMNN) as of Q4 2017, up from 11 in Q3 2017.
- Funds reported $1.82M of Imunon stock for Q4 2017, up 91% quarter-over-quarter.
- 13 funds opened new Imunon positions in Q4 2017 and 4 closed out, a net change of +9 holders.
- The largest Imunon buyer in Q4 2017 was Vanguard Group, an estimated $753K added.
- The largest Imunon seller in Q4 2017 was Renaissance Technologies, an estimated $473K sold.
Based on aggregated 13F filings for Q4 2017.